Cart
0
Orders
AestheFill product image

AestheFill

Compare AestheFill 200 mg by REGEN Biotech: a PDLLA dermal filler with sodium CMC, supplied as one vial per box. Review professional product specifications.
★0(0)
Main Composition
Poly-D,L-lactic acid (PDLLA), Sodium carboxymethylcellulose (CMC)
Country of Origin
South Korea

Product Range


AestheFill
$ 384
200 mg
1 Vial / 1 Box
Not available here
i

Details about AestheFill


Product Overview

AestheFill is a poly-D,L-lactic acid (PDLLA)-based injectable dermal filler manufactured by REGEN Biotech, Inc. in South Korea. The 200 mg presentation contains PDLLA microspheres and sodium carboxymethylcellulose (CMC), supplied as freeze-dried powder in a vial, with one vial per box. For professional product comparison, the 200 mg designation refers to combined powder content, not the amount of PDLLA alone.

Intended use varies by country. Assessment of this product must follow the applicable local labeling and professional supply requirements.

Key Features

  • PDLLA composition: Poly-D,L-lactic acid is the principal distinguishing material; the formulation also contains sodium CMC.
  • Microsphere structure: The manufacturer describes porous PDLLA microspheres with a sponge-like internal structure.
  • 200 mg vial presentation: Freeze-dried powder supplied in a one-vial box, rather than a prefilled syringe.

Composition & Specifications

AestheFill 200 mg presentation
SpecificationDetails
Product typePDLLA-based injectable dermal filler
ManufacturerREGEN Biotech, Inc.
Country of manufactureSouth Korea
Principal materialPoly-D,L-lactic acid (PDLLA) microspheres
Additional formulation componentSodium carboxymethylcellulose (CMC)
FormulationFreeze-dried powder in a vial
Total powder content200 mg per vial; combined formulation content, not PDLLA alone
Box configuration1 vial per box

Storage & Handling

The manufacturer describes room-temperature storage. Follow the supplied market-specific label and instructions for use for exact temperature limits, expiry information and handling requirements.

Frequently Asked Questions

Does AestheFill 200 mg contain 200 mg of PDLLA?

No. The 200 mg designation describes the combined powder content, which includes PDLLA and CMC. It should not be interpreted as a PDLLA-only amount or a liquid concentration.

Is AestheFill a PLLA product?

AestheFill is identified as a PDLLA product: poly-D,L-lactic acid. It should not be cataloged as poly-L-lactic acid (PLLA).

What should professional buyers check before procurement?

Check the exact market label, package configuration, expiry date, applicable instructions for use and local supply permissions. Product information does not establish authorization for sale or use in every country.

Reviews

★0(0)

Loading reviews...